University of Milano Bicocca

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Sep 19, 2026

Recruiting

FORMULA 100: an ICOPE-based Multidomain Intervention to Promote Active and Healthy Ageing.

Sep 10, 2026

Recruiting

Effectiveness of CITicoline (TRAUSAN) in Preventing Cognitive Decline After DELirium in Older Adults With Proximal Hip Fracture - The CITADEL Randomized Controlled Trial

Earlier

Jul 15, 2026TrialSUPER-refractory Status Epilepticus After Cardiac Arrest: a Multicenter, Retrospective, Cohort Study of Dual Anti-glutamate Therapy With Ketamine and Perampanel

Feb 12, 2024TrialPhase 2, Open-label, Single-arm Study on the Use of Metformin as Adjunctive Therapy in High-grade Glioma

Jun 15, 2023TrialVancomycin in Primary Sclerosing Cholangitis in Italy

Oct 1, 2022TrialMonitoring Antiplatelet Drugs in Cardiac Arrest Patients

Jun 1, 2022TrialCharacteristics and Predictors of Liver Injury in Cyclin-dependent Kinase Inhibitors 4/6 (CDK4/6)-Treated Patients With Advanced Breast Cancer

May 19, 2022TrialObservational Retro-prospective Study on PD1/PDL1 Inhibitors Treatment Duration in Patients With NSCLC

4 more events

Nov 14, 2021TrialRegional Citrate Anticoagulation for RRT During V-V ECMO

Oct 14, 2021TrialCOVID-19 and Disease Progression to the Severe Form: a Study on the Use of Monoclonal Antibodies Against SARS-CoV-2

Jun 9, 2021TrialEvaluation of the Immune Response to Sars-Covid-19 Vaccines in Haematological Patients: Prospective Single Center Study

Feb 9, 2021TrialHeterogeneity of Dendritic Cells in Colon and Non-small Cell Lung Cancer

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)